放射性配体

The radioligand was specifically labeled with a positron-emitting isotope for PET imaging.
放射配体被特异性地标记上发射正电子的同位素，用于PET成像。
The researchers synthesized a new radioligand to study the dopamine receptors in the brain.
研究人员合成了一种新的放射配体，用于研究大脑中的多巴胺受体。
The radioligand binding assay provided valuable insights into the interaction between the drug and its target protein.
放射配体结合实验揭示了药物与其靶蛋白之间的重要相互作用。
The radioligand was administered orally to the test subjects, allowing researchers to track its distribution within the body.
将放射配体口服给受试者，以便研究人员追踪其在体内的分布。
The high affinity of the radioligand ensured that it would selectively bind to the desired receptor site.
放射配体的高亲和力确保它会选择性地与目标受体部位结合。
After incubation, the radioactivity bound to the radioligand was measured to quantify receptor occupancy.
孵育后，测量放射性与放射配体的结合，以确定受体占用率。
The radioligand's half-life was crucial in determining the optimal dosing interval for the therapy.
放射配体的半衰期对于确定疗法的最佳给药间隔至关重要。
Researchers optimized the chemical structure of the radioligand to improve its stability and efficacy in vivo.
研究人员优化了放射配体的化学结构，以提高其在体内的稳定性和有效性。
The radioligand was chemically conjugated with a fluorescent molecule for simultaneous visualization and quantification.
放射配体通过化学连接到荧光分子，实现同时可视化和量化。
The radioligand displacement experiment demonstrated the competitive nature of the drug-receptor interaction.
放射配体置换实验显示了药物与受体之间的竞争性相互作用。